IFF Announces Global Price Increases Across All Divisions
IFF (NYSE: IFF) today announced that it is implementing broad-based pricing actions across all four divisions – Nourish, Health & Biosciences, Scent, and Pharma Solutions. The immediate need for these price increases is driven by the continued and significant escalation of raw material, energy and logistics costs as a result of the current geopolitical climate.
Pricing actions will vary by business and be driven by specific product cost increases. These actions will include more frequent pricing reviews – dynamic pricing – to ensure IFF product reflects current market realities.
Actions on specific accounts will be communicated by the respective account managers.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com , Twitter , Facebook , Instagram , and LinkedIn .
© 2022 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LINTONPHARM27.5.2022 15:02:13 CEST | Press release
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting
FEELM27.5.2022 13:40:10 CEST | Press release
FEELM unveils the world's first ceramic coil disposable pod solution at Vaper Expo UK 2022
TYAN27.5.2022 09:02:13 CEST | Press release
TYAN Brings Modern HPC Server Platforms for Data Centers at ISC 2022
MAVENIR27.5.2022 09:02:13 CEST | Press release
Mavenir’s Containerized Open vRAN Small Cell Solution Wins Award for Outstanding Contribution to Emerging Technology or Architecture
MA-TAKEDA/SEAGEN26.5.2022 23:27:07 CEST | Press release
Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom